Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

By S. Arii, Y. Yamaoka, S. Futagawa, Kyoichi Inoue, Kenichi Kobayashi, M. Kojiro, M. Makuuchi, Y. Nakamura, K. Okita, R. Yamada. Hepatology, 2000

728 citations recorded by the source corpus.

Subfields: Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/8de69dbe2d1e45b115604d399ea390640af5a651

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

In Pathology and Forensic Medicine

Citations in the corpus

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. (2010, neutral): “4–6) PVT absent 7 (7) 4 (57) 3 (43) — 6.”
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. (2001, background): “While some series report that survival after percutaneous treatment is usually lower than after surgical resection [69], some cohort studies have failed to detect a significant difference [91,96].”
Novel advancements in the management of hepatocellular carcinoma in 2008. (2008, background): “In early stages, it is not indicated as first-line option, as an outcome review from Japan reported worse results than surgery or percutaneous ablation [11,93].”
Management of hepatocellular carcinoma: An update (2011, neutral): “Long term studies indicate that Child–Pugh A patients with successful tumor necrosis may achieve a 50% survival at 5 years.(28,195,327) This compares well with the outcome of resection in those candidates who do not fit the optimal surgical profile.”
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “Median survival of patients with early HCC reaches 50–70% at 5 years after resection, liver transplantation or local ablation in selected candidates [102,160].”
A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma (2006, result): “In contrast, another large retrospective study of patients with HCC less than 5 cm in diameter enrolled in the Liver Cancer Study Group of Japan found that patients who received liver resection (n 8010) had better survival than PEI (n 4037) or transarterial chemoembolization (n 841).(22) However, th”